February 2, 2017

DSN associate editor David Salazar examines the state of the pharmacy industry, including generics, automation and technology, in this multi-page report.

 

January 4, 2017

DSN associate editor David Salazar examines the state of the pharmacy industry in this multi-page report.

December 7, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of automation and technology, in this multi-page report.

November 14, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of generics, in this multi-page report.

August 3, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy spending, telehealth, generics and technology, in this multi-page report.

June 1, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy technology, in this multi-page report.

April 14, 2016

DSN examines chain pharmacy, including in-depth coverage of specialty pharmacy, orphan drugs and biosimilars, in this multi-page report.

 

December 30, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, specialty pharmacy and top trends, in this multi-page report.

December 9, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, technology, automation, prescription drug home delivery services and Web-based diabetes monitoring, in this multi-page report.

November 11, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, regulations, technology, automation and medication synchronization, in this multi-page report.

October 13, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

September 11, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

August 20, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

July 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation, medication synchronization and generics, in this multi-page report.

June 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation and generics, in this multi-page report.

May 19, 2015

DSN examines chain pharmacy — including in-depth coverage of retail clinics, generics, consolidations, kiosks and more — in this multi-page report.

April 20, 2015

DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.

March 9, 2015

DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.

February 24, 2015

The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change. 

February 4, 2015

DSN examines chain pharmacy, including in-depth coverage of telehealth, generic drug prices, and the GPhA CEO to step down, as well as Uhl appointed director of OGD, in this multi-page report.

January 27, 2015

Rep. Jason Chaffetz, R-Utah, last week introduced a bill that would extend to new combination drugs containing molecules already approved by the Food and Drug Administration the same five-year market exclusivity as a drug product containing an entirely new set of active ingredients.

January 5, 2015

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a Q&A with Owen Mumford's Travis Shaw, in this multi-page report.

December 12, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.

November 18, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.